Rosacea: Subtypes and Targeted Therapies

Overview / Definition Rosacea is a common, chronic inflammatory dermatosis primarily affecting the central face. It is characterized by episodes of facial flushing, persistent erythema, and the development of inflammatory papules and pustules. Rosacea is often misdiagnosed and can significantly impact the quality of life of affected individuals. Epidemiology Rosacea predominantly affects adults, with a peak incidence occurring between the ages of 30 and 50. The condition is more common in women, though men often present with more severe symptoms. Genetic predisposition, environmental factors, and lifestyle choices can influence the prevalence and severity of rosacea. Prevalence: Affects approximately 10% of the population. Higher incidence in individuals with fair skin, particularly those of Celtic descent. Family history of rosacea is observed in many patients. Pathophysiology / Mechanism The exact etiology of rosacea remains unclear, but several factors contribute to its pathogenesis: Vascular dysregulation: Increased blood flow and abnormal vascular responses lead to flushing and persistent erythema. Inflammation: An overactive immune response, particularly involving Demodex folliculorum mites and microbial antigens, triggers inflammatory pathways. Genetic factors: Certain genetic variations may predispose individuals to rosacea. Environmental triggers: Factors such as UV exposure, heat, spicy foods, and alcohol can exacerbate symptoms. Clinical Presentation Rosacea is classified into several subtypes, each with distinct clinical features: Subtype 1 (Erythematotelangiectatic rosacea): Persistent facial erythema, flushing, and visible telangiectasia. Subtype 2 (Papulopustular rosacea): Erythematous papules and pustules resembling acne. Subtype 3 (Phymatous rosacea): Thickened skin and enlargement of the nose (rhinophyma), seen more frequently in men. Subtype 4 (Ocular rosacea): Eye symptoms including dryness, irritation, and conjunctivitis. Diagnosis / Workup The